• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Updates, 19-08-2025: Press Release

    19-08-2025 | 09:45 am

    Glenmark's US arm will launch Micafungin for Injection, a therapeutic equivalent to Mycamine. This product targets an annual market of ~$60.7 million, expanding Glenmark's institutional portfolio and offering affordable alternatives for patients.

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited